Completed
OBSERVATIONAL
NCT02571673
Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
This study is being done to understand how survivors of head and neck cancer think they can make HN-STAR (the Survivor Self-Assessment, the survivorship clinic experience, and the Survivorship Care Plan the best it can be. Once the investigators have your input and input from other survivors, they can make changes to HN-STAR, so that they can test this tool in a larger study. The larger study will tell them whether using HN-STAR improves the care of head and neck cancer survivors.
Interventions
Name:
Assessments
Type:
BEHAVIORAL
Description:
Usability outcomes will come from patient surveys and interviews and a nurse practitioner interview in Aim 1: Part 1. In Aim 1: Part 2, patients and their primary care providers will complete online surveys regarding feasibility. Health outcomes and data regarding health care actions will be collected from HN-STAR and the clinic note will be collected to assess feasibility of collecting these metrics in a future trial. Directly after each clinic visit, the NP will complete one brief online survey for each participant.
Primary Outcomes
Measure:
Recommendations for Cancer Surveillance (Patient-reported Outcomes From the Survivor Self-Assessment)
TimeFrame:
2 years
Description:
Using data from survivors in Aim 1: Part 2 (N=45), we will abstract data on health care actions from both the medical record and HN-STAR. Such data include receipt of appropriate oncologic surveillance, identification and management of symptoms, and appropriate preventive health services, as indicated by referrals, prescriptions, and recommendations in both clinic notes and the HN-STAR Survivor Self-Assessment. For each participant, HN-STAR generates a Treatment Summary/TS for the clinician to review and verify its accuracy compared with clinical documentation with the participant medical record.
Trial Information
NCT ID
NCT02571673
Status
Completed
Study Type
OBSERVATIONAL
Sponsor
Memorial Sloan Kettering Cancer Center
Last Updated
December 15, 2025